Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

HOWL Werewolf Therapeutics

Watchlist
3.790
+0.080+2.16%
Close  02/03 16:00 ET
3.7900.0000.00%
Post Mkt Price 02/03 16:03 ET
High
3.939
Open
3.610
Turnover
269.14K
Low
3.600
Pre Close
3.710
Volume
70.96K
Market Cap
116.52M
P/E(TTM)
Loss
52wk High
8.150
Shares
30.74M
P/E(Static)
Loss
52wk Low
1.390
Float Cap
38.69M
Bid/Ask %
33.33%
Historical High
23.990
Shs Float
10.21M
Volume Ratio
0.43
Historical Low
1.390
Dividend TTM
--
Div Yield TTM
--
P/B
0.89
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.70%
Amplitude
9.14%
Avg Price
3.792
Lot Size
1
Float Cap
38.69M
Bid/Ask %
33.33%
Historical High
23.990
Shs Float
10.21M
Volume Ratio
0.43
Historical Low
1.390
Dividend TTM
--
P/B
0.89
Dividend LFY
--
Turnover Ratio
0.70%
Amplitude
9.14%
Avg Price
3.792
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.
CEO: Dr. Daniel J. Hicklin,, PhD
Market: NASDAQ
Listing Date: 04/30/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist